This study is developing a new diagnostic test called Bladder EpiCheck. This test uses a urine sample to help detect bladder cancer or monitor for its return in people who have had it before. We are looking for 1000 participants aged 22 or older who are suspected of having bladder cancer or are undergoing surveillance for non-muscle invasive bladder cancer (NMIBC). The main goal is to collect urine samples to help improve the Bladder EpiCheck test. This is an observational study, meaning you won't receive a new treatment, but your samples will help develop a new diagnostic tool.

Study design

This is an observational study planning to enroll 1000 participants. It is not testing a treatment, but rather collecting information to develop a diagnostic test.

What's involved

You would have a single visit where you sign a consent form and provide a urine sample. Information about your demographics and any pathology results will also be collected.

Compensation

Not stated in the trial record.

Follow-up

The primary objective is measured at 1 year, but the record does not specify if participants have follow-up visits after the initial single visit.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.